Can you imagine waking up in a house unrecognisably new to you every morning for the rest of your life? Not being able to find your kitchen to make a cup of tea? Not being able to recognise your loved ones? Most of us cannot conceive these situations, but they are the reality for millions of patients with Alzheimer’s disease (AD) worldwide.
Patient experiences are diverse and dynamic. Mapping patient journeys enables us to unlock salient insights and redesign care pathways.
Brian Parsons, joint MD of the Porterhouse Medical Group and advocacy expert, highlights the importance of advocacy and how to get the best from advocacy programmes in the pharmaceutical industry.
In late 1846, a dentist from New England, William TG Morton, is attributed to have performed a dental extraction using diethyl ether as a general anaesthetic. While there was much subsequent debate around who pioneered the birth of modern anaesthesia, what is undeniable is the speed with which the practice spread among the medical profession and the impact it had on medicine.1
World Multiple Sclerosis (MS) Day is an initiative of the MS International Federation that is marked on 30 May every year. The 2018 campaign called #bringinguscloser focuses on research and connecting those affected by MS to those involved in researching it
There’s no substitute for face-to-face meetings. But meetings require a significant investment, with often substantial venue and travel costs, as well as the opportunity costs of the audience and organiser’s time. Therefore, it’s vital for meeting owners to maximise the value of their investment, and for attendees to feel like it was a worthwhile use of their time.
The Rare Disease Day campaign aims to combat these issues by raising awareness among the public, healthcare professionals, researchers, industry, and policy decision-makers.